T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shocking diabetes treatment? new procedure aims to reset the gut
Disease control Not yet recruitingThis study tests a procedure called ReCET that uses mild electrical pulses to treat the lining of the small intestine. It aims to improve blood sugar control and reduce fat in the liver for people with type 2 diabetes and fatty liver disease who haven't had success with standard …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 17, 2026 09:01 UTC
-
Can this diabetes pill protect your kidneys? major trial launches
Disease control Not yet recruitingThis study tests whether adding ganagliflozin tablets to standard treatment can slow kidney disease in people with type 2 diabetes and chronic kidney disease. About 1,244 adults will take either the drug or a placebo for 120 weeks. The main goal is to see if the drug helps preser…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New once-daily pill aims to simplify diabetes care in china
Disease control Not yet recruitingThis study will test a new once-daily tablet that combines three diabetes drugs (henagliflozin, retagliptin, and metformin) in about 300 Chinese adults with type 2 diabetes. The goal is to see how well it controls blood sugar and its safety over 24 weeks. Participants include new…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New triple therapy aims to shield kidneys in diabetes patients
Disease control Not yet recruitingThis study looks at whether adding a third medication (dulaglutide) to an existing two-drug regimen can provide extra kidney protection for Chinese adults with type 2 diabetes and mild-to-moderate chronic kidney disease. About 468 participants will either continue their current t…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New drug combo aims to reverse fatty liver damage in diabetics
Disease control Not yet recruitingThis study tests whether a drug called chiglitazar, combined with anti-inflammatory and liver-protecting treatments, can help people with both type 2 diabetes and a serious fatty liver disease called MASH. About 300 adults will receive either the combination or a placebo to see i…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New diabetes combo pill put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis study checks if a new tablet that combines two diabetes drugs (Chiglitazar and Metformin) is absorbed the same way as the standard separate tablets. It involves 64 healthy adults aged 18-45 who take a single dose of each version after a meal. The goal is to see if the new co…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
New diabetes combo pill tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new combination pill for type 2 diabetes in 28 healthy Chinese adults. It has two parts: one checks how a high-fat meal changes drug levels in the blood, and the other looks at how the drug builds up with repeated doses. The goal is to gather safety…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
New diabetes combo pill put to the test in healthy adults
Knowledge-focused Not yet recruitingThis study checks if a new tablet combining two diabetes drugs (Chiglitazar and Metformin) works the same as taking them separately. It involves 24 healthy adults who take a single dose of each version under fed conditions. The goal is to measure how the drug moves through the bo…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC